Pillstats
Rx only · Injection, Powder, For Solution · Intramuscular

Ceftriaxone Sodium

Ceftriaxone Sodium

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US27 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)2193
US makers9 labelers
Packages43
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 22 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.676$1.35$2.03$2.70Feb 2025Feb 2026Jul 2026
$1.678
Latest avg · Jul 22, 2026
+34%
Since Feb 19, 2025
9
Active US suppliers
35%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

94K188K281K375K2025 Q12025 Q22025 Q32025 Q42026 Q1
239K
Rx · 2026 Q1
412K
Units dispensed
-27%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Hospira, Inc.unknown8SUPPLYING
Sandoz Incunknown7SUPPLYING
Apotex Corp.unknown7SUPPLYING
Qilu Pharmaceutical Co. Ltd.unknown6SUPPLYING
Sportpharm LLCunknown4SUPPLYING
Proficient Rx LPunknown4SUPPLYING
A-S Medication Solutionsunknown4SUPPLYING
Asclemed USA, Inc.unknown2SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Oct 19, 2016
    RECALLRecall (Class III): Ceftriaxone for Injection, USP, 1 gram, 10 Single use Vials, Rx only, For IM or I.V. Use, Manufactured by: Sandoz GMbH …

    Labeling: Missing Label — Recalling firm: Sandoz Inc — WI